BioSpace News Archive

Alcresta Therapeutics, Inc. today announced publication of preclinical data from the company’s development device ALC-078 in a porcine short bowel syndrome (SBS) model.

Caira Surgical announced that Jon Greenwald, Chief Executive Officer, will present at the fourth annual Life Science Intelligence USA ’23 Emerging Medtech Summit on March 22, 2023, at 11:30 a.m. PT in Dana Point, California.

Alcami Corporation, a leading contract development and manufacturing organization, announced the promotion of Ken Morgan to Chief Financial Officer.

TC BioPharm today announced that the Company has been granted a formal extension to regain compliance under Nasdaq Listing Rule 5550(b)(2),

BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) announces today that its CEO Amir Reichman will be presenting in-person at the 17th annual BIO-Europe Spring taking place March 20–22, 2023, in Basel, Switzerland.

Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that additional data from its pivotal Phase 3 VIITAL™ study of EB-101 for recessive dystrophic epidermolysis bullosa (RDEB) has been accepted for an oral presentation at the inaugural International Societies for Investigative Dermatology (ISID) Meeting, being held May 10-13, 2023 in Tokyo, Japan.

NeuroOne Medical Technologies Corporation announced the successful completion of an initial animal implant of its novel thin film paddle leads for spinal cord stimulation.

AIM ImmunoTech Inc. announced a late-breaking presentation at the 36th International Conference on Antiviral Research detailing Ampligen’s mechanism of action in the treatment of Ebola virus disease.

Actinium Pharmaceuticals, Inc. announced today that two abstracts have been accepted for presentation at the American Association for Cancer Research (AACR) 2023 Annual Meeting being held April 14 - 19, 2023 in Orlando, Florida.

Neuronetics, Inc. is named a recipient of Life Sciences Pennsylvania’s annual Patient Impact Award for 2022.